Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Viridian Therapeutics, Inc.\DEexh_321.htm
EX-31.2 - EXHIBIT 31.2 - Viridian Therapeutics, Inc.\DEexh_312.htm
EX-31.1 - EXHIBIT 31.1 - Viridian Therapeutics, Inc.\DEexh_311.htm
EX-21.1 - EXHIBIT 21.1 - Viridian Therapeutics, Inc.\DEexh_211.htm
10-K - FORM 10-K - Viridian Therapeutics, Inc.\DEf10k_032417p.htm

Exhibit 23.1



Consent of Independent Registered Public Accounting Firm



Miragen Therapeutics, Inc. (formerly Signal Genetics, Inc.)

Boulder, Colorado


We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-205620 and 333-205618) and Form S-8 (Nos. 333-197316, 333-213142 and 333-216112) of Miragen Therapeutics, Inc. (formerly Signal Genetics, Inc.) of our report dated March 24, 2017, relating to the consolidated financial statements which appear in this Form 10-K.




San Diego, California


March 24, 2017